Page last updated: 2024-08-21

perfluorobutane and Coronary Restenosis

perfluorobutane has been researched along with Coronary Restenosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abizaid, A; Colombo, A; Dangas, G; Hellinga, D; Iversen, P; Iyer, S; Kipshidze, NN; Leon, MB; Moses, JW; Porter, TR; Roubin, G; Seabron, R; Tio, F; Waksman, R; Wolfram, R; Xie, F; Yazdi, H1

Other Studies

1 other study(ies) available for perfluorobutane and Coronary Restenosis

ArticleYear
Novel site-specific systemic delivery of Rapamycin with perfluorobutane gas microbubble carrier reduced neointimal formation in a porcine coronary restenosis model.
    Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2005, Volume: 64, Issue:3

    Topics: Animals; Blood Vessel Prosthesis Implantation; Blotting, Western; Cell Cycle Proteins; Chromatography, High Pressure Liquid; Coronary Restenosis; Coronary Vessels; Cyclin-Dependent Kinase Inhibitor p27; Disease Models, Animal; Drug Delivery Systems; Fluorocarbons; Follow-Up Studies; Humans; Immunosuppressive Agents; Infusions, Intra-Arterial; Microbubbles; Sirolimus; Stents; Swine; Tumor Suppressor Proteins; Tunica Intima

2005